Get the Stockscreener App
37.42
0.80%
-0.30
Xoma Royalty Corp stock is traded at $37.42, with a volume of 28,668.
It is down -0.80% in the last 24 hours and up +31.48% over the past month.
XOMA Royalty Corp is a biotechnology royalty aggregator playing a role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceuticals or biotechnology companies. XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Geographically, the company operates in Switzerland, United States, Asia Pacific, Europe and Others.
See More
Previous Close:
$37.72
Open:
$37.98
24h Volume:
28,668
Relative Volume:
0.49
Market Cap:
$452.32M
Revenue:
$9.71M
Net Income/Loss:
$-29.96M
P/E Ratio:
-10.75
EPS:
-3.48
Net Cash Flow:
$-14.79M
1W Performance:
+6.19%
1M Performance:
+31.48%
6M Performance:
+76.84%
1Y Performance:
+34.75%
1-Day Range:
$37.00
$37.98
1-Week Range:
$33.59
$38.00
52-Week Range:
$18.35
$38.00
Xoma Royalty Corp Stock (XOMA) Company Profile
Name
Xoma Royalty Corp
Sector
Industry
Phone
510-204-7239
Address
2200 POWELL STREET, EMERYVILLE, CA
Compare XOMA with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
XOMA
Xoma Royalty Corp
|
37.42 | 442.17M | 9.71M | -29.96M | -14.79M | -3.48 |
|
VRTX
Vertex Pharmaceuticals Inc
|
394.53 | 99.62B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
465.89 | 61.52B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
560.00 | 58.91B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
756.38 | 46.69B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
324.34 | 34.54B | 3.81B | -644.79M | -669.77M | -6.24 |
Xoma Royalty Corp Stock (XOMA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-17-25 | Initiated | The Benchmark Company | Buy |
| Apr-29-24 | Initiated | Leerink Partners | Outperform |
| Sep-07-21 | Downgrade | Wedbush | Outperform → Neutral |
| Jun-29-21 | Initiated | Aegis Capital | Buy |
| Jan-19-21 | Reiterated | H.C. Wainwright | Buy |
| Jan-18-18 | Reiterated | H.C. Wainwright | Buy |
| Oct-17-17 | Resumed | H.C. Wainwright | Buy |
| Sep-05-17 | Upgrade | Wedbush | Neutral → Outperform |
| Jun-12-17 | Initiated | H.C. Wainwright | Buy |
| Nov-14-16 | Downgrade | Wedbush | Outperform → Neutral |
| Mar-11-16 | Reiterated | Wedbush | Outperform |
| Jul-23-15 | Downgrade | Jefferies | Buy → Hold |
| Jul-22-15 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Jul-22-15 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Oct-10-14 | Resumed | ROTH Capital | Buy |
| Apr-29-14 | Upgrade | MLV & Co | Hold → Buy |
| Mar-11-14 | Downgrade | MLV & Co | Buy → Hold |
| Mar-05-14 | Reiterated | Ladenburg Thalmann | Buy |
| Oct-31-13 | Reiterated | MLV & Co | Buy |
| May-09-13 | Reiterated | Ladenburg Thalmann | Buy |
| May-14-12 | Initiated | Cowen & Co | Outperform |
| Mar-31-11 | Reiterated | MLV Capital | Buy |
| Mar-23-11 | Reiterated | RBC Capital Mkts | Outperform |
| Jan-06-11 | Reiterated | Ladenburg Thalmann | Buy |
| Jan-04-11 | Reiterated | Wedbush | Outperform |
View All
Xoma Royalty Corp Stock (XOMA) Latest News
XOMA Royalty (NASDAQ:XOMA) Upgraded at Zacks Research - Defense World
Real time breakdown of XOMA Royalty Corporation stock performanceWeekly Trade Recap & High Accuracy Investment Entry Signals - Newser
Will XOMA Royalty Corporation benefit from macro trendsJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
What MACD signals say about XOMA Royalty CorporationJuly 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
How to integrate XOMA Royalty Corporation into portfolio analysis toolsJuly 2025 Retail & Consistent Profit Trade Alerts - Newser
Measuring XOMA Royalty Corporation’s beta against major indices2025 Valuation Update & Stepwise Entry and Exit Trade Signals - Newser
Applying Wyckoff theory to XOMA Royalty Corporation stockJuly 2025 Opening Moves & Weekly Momentum Stock Picks - Newser
XOMA Royalty Corporation stock outlook for YEARJuly 2025 Movers & Daily Risk Controlled Trade Plans - Newser
Nuveen LLC Invests $286,000 in XOMA Royalty Corporation $XOMA - MarketBeat
How hedge fund analytics apply to XOMA Royalty Corporation stockGold Moves & Weekly Top Gainers Alerts - Newser
Real time alert setup for XOMA Royalty Corporation performanceJuly 2025 Update & AI Forecasted Entry/Exit Points - Newser
Price action breakdown for XOMA Royalty CorporationJuly 2025 Setups & Daily Volume Surge Trade Alerts - Newser
Will XOMA Royalty Corporation see short term momentumLayoff News & Verified Short-Term Plans - Newser
Will breakout in XOMA Royalty Corporation lead to full recoveryJuly 2025 Trade Ideas & Daily Technical Forecast Reports - Newser
Smart tools for monitoring XOMA Royalty Corporation’s price action2025 Earnings Impact & Capital Protection Trading Alerts - Newser
Benchmark raises XOMA stock price target to $50 on strong earnings - Investing.com
Is XOMA Royalty Corporation stock reversal real or fakeMarket Activity Recap & Precise Entry and Exit Recommendations - Newser
What to do if you’re stuck in XOMA Royalty CorporationBreakout Watch & Weekly High Return Stock Forecasts - Newser
Using data filters to optimize entry into XOMA Royalty CorporationJuly 2025 Sentiment & Accurate Buy Signal Notifications - Newser
Will XOMA Royalty Corporation outperform the marketMarket Trend Report & Stock Portfolio Risk Control - Newser
Is a relief rally coming for XOMA Royalty Corporation holders2025 Breakouts & Breakdowns & Free Expert Verified Stock Movement Alerts - Newser
Can momentum traders help lift XOMA Royalty CorporationWeekly Trade Recap & High Accuracy Trade Alerts - Newser
Is XOMA Royalty Corporation reversing from oversold territoryWeekly Profit Analysis & Smart Allocation Stock Reports - Newser
What does recent volatility data suggest for XOMA Royalty CorporationDollar Strength & Verified Chart Pattern Trade Signals - Newser
Advanced analytics toolkit walkthrough for XOMA Royalty Corporation2025 Momentum Check & Daily Stock Momentum Reports - Newser
Predicting XOMA Royalty Corporation trend using moving averagesWall Street Watch & Safe Swing Trade Setups - Newser
Should I buy XOMA Royalty Corporation stock now2025 Technical Patterns & Smart Allocation Stock Tips - khodrobank.com
How to use Fibonacci retracement on XOMA Royalty CorporationJuly 2025 Outlook & Weekly Top Gainers Alerts - Newser
What to expect from XOMA Royalty Corporation in the next 30 daysGold Moves & Low Drawdown Trading Strategies - Newser
Tools to assess XOMA Royalty Corporation’s risk profileDividend Hike & Long-Term Growth Plans - Newser
Wall Street Analysts Predict an 86.05% Upside in XOMA Royalty (XOMA): Here's What You Should Know - Yahoo Finance
XOMA Royalty Corporation Executives to Present Company Update at H.C. Wainwright 27th Annual Global Investment Conference - Quiver Quantitative
XOMA Royalty to Present at H.C. Wainwright 27th Annual Global Investment Conference - GlobeNewswire
Biotech Royalty Aggregator XOMA to Present Strategic Update at H.C. Wainwright Global Investment Conference - Stock Titan
Statistical indicators supporting XOMA Royalty Corporation’s strength2025 Trade Ideas & Reliable Intraday Trade Alerts - Newser
Can volume confirm reversal in XOMA Royalty Corporation2025 Momentum Check & Free Expert Verified Stock Movement Alerts - Newser
Xoma Royalty Corp Stock (XOMA) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):